Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO
16/03/2026 01:06
March 16 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: MICHAEL THURN RESIGNS AS MANAGING DIRECTOR AND CEO SERGIO DUCHINI TO ASSUME ROLE OF EXECUTIVE CHAIR UNTIL NEW CEO APPOINTED Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility